pharmaceutical daily

January 5, 2017 Off

Ceylad kicks off THINK cancer trial in Belgium, blood taken from the first patient

Celyad has started on Thursday its Therapeutic Immunotherapy with NKR-2 (THINK) trial in Belgium with the first patient giving blood.
To remind, THINK trial is an open-label Phase Ib study to assess the safety and clinical activity of multiple administrations of autologous CAR-T NKR-2 cells in seven refractory cancers.

January 5, 2017 Off

Valneva, Merck in new animal vaccines deal (U.S.&Canada)

By Dino Mustafić

Valneva has given Merck in United States and Canada rights to use its EB66 technology to research new veterinary vaccines.

January 5, 2017 Off

Futura Medicals launches condom in Saudi Arabia, expects further distribution in MENA

By Dino Mustafić

Transdermal technology specialist Futura Medicalis has made an – at least to say – interesting step in Saudi Arabia, country…

January 5, 2017 Off

OptiBiotix replaces Commercial Director

By Dino Mustafić

OptiBiotix Health is rearranging its directorial staff as it has changed its Commercial Director. Namely, Jim Laird will be substituted by Per Rehné to that directorial position.

January 5, 2017 Off

Nicox provides clinical and regulatory update for NCX 4251 in blepharitis

By Dino Mustafić

Nicox has provided certain regulatory and clinical updates for NCX 4251, its novel ophthalmic suspension of fluticasone propionate nanocrystals being…

January 5, 2017 Off

Neovacs and Professor Robert Kerbel together fight cancer

By Dino Mustafić

Neovacs and Professor Robert Kerbel and his team at the Sunnybrook Research Institute of Toronto, Canada are about to join…

January 4, 2017 Off

Bayer nets FDA’s priority review for cancer drug in U.S.

By Dino Mustafić

Bayer has started off the new year with another approval from theU.S. Food and Drug Administration (FDA).

January 4, 2017 Off

Sanofi’s type 2 diabetes drug available in U.S.

By Dino Mustafić

Sanofi’s Soliqua 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by prescription in U.S. pharmacies.

January 4, 2017 Off

J&J’s DePuy Synthes acquires Interventional Spine expandable cage technology

By Dino Mustafić

J&J’s DePuy Synthes Products, Inc. has bought asset and signed development agreement with Interventional Spine, Inc., a privately held manufacturer…

January 4, 2017 Off

Eli Lilly’s subsidiary Elanco buys BIVI

By Dino Mustafić

Eli Lilly’s subsidiary Elanco US has completed the acquisition of Boehringer Ingelheim Vetmedica, Inc’s (BIVI) U.S. feline, canine and rabies vaccines…